By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Synthetic Biologics, Inc. 

3930 Varsity Drive

Ann Arbor  Michigan  48108  U.S.A.
Phone: 734-332-7800 Fax: 734-332-7878


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Synthetic Biologics, Inc. (SYN)' Statin-Class Candidate For Constipation-Predominant Irritable Bowel Syndrome Detailed At Company's Investor Day 9/16/2014 10:07:15 AM
Synthetic Biologics, Inc. (SYN) Receives Orphan Drug Designation For SYN-005 Treatment For Whooping Cough (Pertussis) 9/12/2014 11:32:36 AM
Synthetic Biologics, Inc. (SYN) To Host Phase 2 Trimesta™ For Multiple Sclerosis Conference Call 9/11/2014 8:17:07 AM
Synthetic Biologics, Inc. (SYN) To Webcast September 16, 2014 Irritable Bowel Syndrome (IBS) Investor Day 9/10/2014 11:58:37 AM
Synthetic Biologics, Inc. (SYN) Highlights SYN-005 Data Presented At The 54th ICAAC From Novel Whooping Cough (Pertussis) Program 9/8/2014 8:36:30 AM
Synthetic Biologics, Inc. (SYN) To Present At The 16th Annual Rodman & Renshaw Global Investment Conference In New York City 9/3/2014 4:10:14 PM
Synthetic Biologics, Inc. (SYN) To Initiate Clinical Trials Of SYN-004 In 4Q 2014 To Prevent Potentially Deadly C. difficile Infections 9/3/2014 3:45:28 PM
Synthetic Biologics, Inc. (SYN) And Fujifilm Diosynth Biotechnologies Announce Significant Improvement In API Manufacturing Of SYN-004 For The Prevention Of C. Difficile 8/28/2014 11:32:39 AM
Synthetic Biologics, Inc. (SYN) Announces Presentation Of Poster for SYN-004 C. difficile Program At IDWeek 2014™ 8/26/2014 9:38:48 AM
Synthetic Biologics, Inc. (SYN) Announces Late-Breaking Poster Presentation For C. Difficile Program At 54th ICAAC 8/19/2014 8:20:54 AM
12345678910...
//-->